Gonococcal arthritis study (2014-2024)
Part of Bones, joints & muscles, Infections clinical trials.
This study looks at people who had a joint infection caused by gonorrhea bacteria between 2014 and 2024. Researchers want to learn more about how common this condition is and how it affects people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a joint infection that tested positive for gonorrhea between 2014 and 2024.
- You do not object to your medical records being used for this study.
- You are not under legal guardianship, curatorship, or similar legal protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who have had a joint replacement and may have an infection around it, or for people getting their first joint replacement. It looks at fluid from the joint to help doctors diagnose infections more accurately.
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
This study examines joint tissue from people with different types of arthritis to understand the disease better. It may help researchers develop better treatments in the future.
This study looks for Lyme bacteria in people with new arthritis in one or a few joints to see if Lyme disease is an under-recognized cause of joint swelling.
This trial looks at infections in hip, knee, or shoulder replacements in people who needed critical care and later passed away. It aims to learn from their medical information to better prevent and treat similar infections.
This trial analyzes throat bacteria in partners of people with gonorrhea to better understand the infection. It may help improve detection and care for those at risk.
Hear when a new Gonococcal (GC) Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.